Sérgio A. Lira, is a Brazilian-born American immunologist who pioneered the use of genetic approaches to study the function of chemokines.[1] His early studies were the first to show that chemokines played a major role on leukocyte trafficking to the brain, the lung and the thymus.[2]
Lira is currently the Leona M. and Harry B. Helmsley Charitable Trust Professor of Immunology at the Mount Sinai School of Medicine and previous co-director/director of the Immunology Institute at the Mount Sinai Medical Center (2007-2013 as co-director and 2013-2016 director), both in New York City.[3] He is the author of more than 120 published articles.
Lira organized the 2003 Keystone Symposium on Chemokines and the 2006 Gordon Research Conference on Chemotactic Cytokines.[4] He was elected to the Henry Kunkel Society in 2006 and to the Association of American Physicians in 2008.[3] He received the Inventor’s Award (in 2000) and the Impact Award (in 1998) from the Schering-Plough Research Institute.[3]
Areas of research
Lira’s lab pioneered the use of genetic approaches to study the function of chemokines during homeostasis and disease conditions.[1] Other contributions include studies on the mechanisms of lymphoid neogenesis and on the biological function of molecules encoded by viruses that mimic chemokines, including the discovery that the chemokine receptor encoded by herpesvirus 8 is an oncogene, a discovery that led to important insights into the mechanisms leading to the development of Kaposi’s sarcoma.[6] Lira’s lab has also made important contributions to the study of IL-23, a cytokine that affects development of inflammatory and autoimmune conditions.[7]
Honors and awards
Max Planck Gesellschaft (Germany) - Student Fellowship. February 1980 - June 1980.
International Endocrine Society - Travel Award. International Congress of Endocrinology, Kyoto, Japan. 1988.
President's Award - Bristol-Myers Squibb Company. 1995
Impact Award - Schering-Plough Research Institute. 1998
Inventor’s Award - Schering-Plough Research Institute. 2000
Irene Diamond Associate Professorship in Immunology Award – July 2002.
Jamieson, T; Cook, DN; Nibbs, RJB; Rot, A; Nixon, C; McLean, P; Alcami, A; Lira, SA; Wiekowski, M; et al. (2005). "The chemokine receptor D6 limits the inflammatory response in vivo". Nat Immunol. 6 (4): 403–411. doi:10.1038/ni1182. PMID15750596. S2CID33588361.
Cua, DJ; Sherlock, J; Chen, Y; Murphy, CA; Joyce, B; Seymour, B; Lucian, L; To, W; Kwan, S; et al. (2003). "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain". Nature. 421 (6924): 744–748. Bibcode:2003Natur.421..744C. doi:10.1038/nature01355. PMID12610626. S2CID4380302.
Nelson, C; Crenshaw, EB; Franco, R; Lira, SA; Albert, VR; Evans, RM; Rosenfeld, MG. (1986). "Discrete cis-active genomic sequences dictate the pituitary cell type-specific expression of rat prolactin and growth hormone genes". Nature. 322 (6079): 557–562. Bibcode:1986Natur.322..557N. doi:10.1038/322557a0. PMID3736673. S2CID4324841.
References
^ abReboldi A, Coisne C, Baumjohann D, Benvenuto F, Bottinelli D, Lira S, Uccelli A, Lanzavecchia A, Engelhardt B, Sallusto F (May 2009). "C-C chemokine receptor 6-regulated entry of TH-17 cells into the CNS through the choroid plexus is required for the initiation of EAE". Nat. Immunol. 10 (5): 514–23. doi:10.1038/ni.1716. PMID19305396. S2CID205362290.
^ abGerd Folkers; Martine J. Smit; Sergio A. Lira; Leurs, Rob; Raimund Mannhold; Hugo Kubinyi (2010). Chemokine Receptors as Drug Targets (Methods and Principles in Medicinal Chemistry). Weinheim: Wiley-VCH. ISBN978-3-527-32118-6.
^Cua DJ, Sherlock J, Chen Y, Murphy CA, Joyce B, Seymour B, Lucian L, To W, Kwan S, Churakova T, Zurawski S, Wiekowski M, Lira SA, Gorman D, Kastelein RA, Sedgwick JD (February 2003). "Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain". Nature. 421 (6924): 744–8. Bibcode:2003Natur.421..744C. doi:10.1038/nature01355. PMID12610626. S2CID4380302.